Patents
Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798)
05/2009
05/27/2009CN100490881C Preparation method of food-digesting spleen-invigorating oral liquid containing micrometer chickens gizzard-membrane powder, coix seed powder, white hyacinth bean powder, yam powder, pine pollen powde
05/27/2009CN100490872C Kidney tonifying oral liquid made of American ginseng and cordyceps
05/27/2009CN100490869C Formulation with six ingredients containing rehmanniae
05/27/2009CN100490864C Yin-nourishing fatigue-relieving capsules
05/27/2009CN100490863C Preparing process of antiphlogistic Chunwang capsule
05/27/2009CN100490862C Preparation method of intestine-moistening face-beautifying granule and capsule with micron pine pollen, cactus, ganoderma lucidum and wolfberry fruit powder
05/27/2009CN100490861C Preparation method of liver-benefiting face-beautifying wine with micron pine pollen and pearl powder for women
05/27/2009CN100490860C Preparation method of liver-benefiting face-beautifying oral liquid with micron pine pollen and pearl powder for women
05/27/2009CN100490849C Method for preparing houttuynia freeze-dried powder injection
05/27/2009CN100490846C Medicine for improving sleep and nourishing bowel and relieving constipation and its preparation
05/27/2009CN100490845C Herbal composition and its use in chemotheraphy
05/27/2009CN100490834C Preparation method of kidney-tonifying fatigue-eliminating oral liquid containing micropilose antler, safflower seeds etc.
05/27/2009CN100490832C Method for preparing kidney-warming face-nourishing liquor containing micron pine pollen, deer placenta powder, glossy privet fruit powder, white fungus, safflower etc.
05/27/2009CN100490831C Method for preparing kidney-warming face-nourishing oral liquid containing micron pine pollen, deer placenta powder, glossy privet fruit powder, white fungus, safflower etc.
05/27/2009CN100490829C Selenium-rich hedgehog fungus extract preparation for treating colitis, gastritis and stomach cancer and its preparing process
05/27/2009CN100490823C Pharmaceutical compositions for the oral administration of heparin or derivatives thereof
05/27/2009CN100490821C New use of tremella heteropolysaccharide or its extract
05/27/2009CN100490811C Piperazine derivative used as CCRS antagonist
05/27/2009CN100490806C Oral dispersion domperidone coutrolled-release gel and its preparing method
05/27/2009CN100490798C Quick disintegrated tablet or oral cavity disintegrated tablet containing L-glutamic acid and azulene sodium sulfonate and making method thereof
05/27/2009CN100490792C Use of Teroo hydrochloride and its chemical analog in preparation of anti-liver fibrotic medicine
05/27/2009CN100490790C Enteric coated omeprazole pellets capsule and the preparing method thereof
05/27/2009CN100490777C Chinese medicinal tooth-strengthening powder for treating dental disease and its manufacturing method
05/27/2009CN100490776C Oral compositions providing optimal surface conditioning
05/27/2009CN100490659C Method for preparing bowel-lubricating, face-beautifying yoghurt with micron pine pollen, cactus powder, glossy ganoderma powder and medlar
05/26/2009US7538215 Compounds which inhibit leukocyte adhesion mediated by VLA-4
05/26/2009US7538121 Vanilloid receptor modulators
05/26/2009US7538118 6-aminomorphinane derivatives, method for production and use thereof
05/26/2009US7538089 Anti-inflammatory compounds and uses thereof
05/26/2009US7537887 Relates to regulation of activity of NET (ERP/SAP-2) protein and to compounds which modify or regulate NET protein activity; methods of screening for agonists or antagonists of NET in order to identify new pro- or anti-angiogenic compounds
05/26/2009CA2497857C Novel p-selectin ligand protein
05/26/2009CA2494165C Method for the preparation of a silicic acid comprising extrudate, said extrudate, its use and a pharmaceutical composition comprising the said extrudate
05/26/2009CA2474373C N-biphenylmethyl aminocycloalkanecarboxamide derivatives with a substituent on the methyl useful as bradykinin antagonists
05/26/2009CA2463264C 3-azabicyclo (3.1.0) hexane derivatives as opioid receptor antagonists
05/26/2009CA2367017C Inhibitors of impdh enzyme
05/26/2009CA2345100C Optimized use of 6-mercaptopurine drug in the treatment of immune-mediated gastrointestinal disorders
05/26/2009CA2344058C Diaminopropionic acid derivatives
05/26/2009CA2334773C Benzothiepine-1,1-dioxide derivatives, method for producing them, medicaments containing these compounds and their use
05/26/2009CA2295936C Chimeric interleukin-6 soluble receptor/ligand protein, analogs thereof and uses thereof
05/26/2009CA2254420C Substituted imidazolidine derivatives, their preparation, their use and pharmaceutical preparations comprising them
05/26/2009CA2225903C Aromatic diselenides and selenosulfides, their preparation and their uses, more particularly their therapeutical use
05/26/2009CA2091102C Microsomal triglyceride transfer protein
05/22/2009WO2009064819A2 Compositions for the treatment of gastrointestinal inflammation
05/22/2009WO2009064460A2 Gastrointestinal delivery systems
05/22/2009WO2009064458A2 Compositions for the treatment of inflammation of the gastrointestinal tract
05/22/2009WO2009064417A2 Compositions for the treatment of gastrointestinal inflammation
05/22/2009WO2009064156A1 Novel composition obtained from labisia pumila extract for hepatoprotective activity
05/22/2009WO2009063993A1 Fused pyridine derivative and use thereof
05/22/2009WO2009063992A1 Condensed pyridine derivative and use thereof
05/22/2009WO2009063991A1 Pyridooxazepine derivative and use thereof
05/22/2009WO2009063990A1 Benzazepinone compound
05/22/2009WO2009063987A1 Novel use of processed ginseng
05/22/2009WO2009063248A2 Polymorphic forms of tegaserod glutarate
05/22/2009WO2009063247A1 Novel crystalline forms
05/22/2009WO2009063221A2 Methods of treating or preventing inflammatory diseases of the intestinal tract
05/22/2009WO2009062737A1 Silibinin component for the treatment of hepatitis
05/22/2009WO2009027852A3 Methods and compositions for treating gastrointestinal conditions
05/22/2009WO2008068593A8 Motilide polymorphs
05/22/2009WO2008040548A3 Treatment for non-alcoholic-steatohepatitis
05/22/2009CA2705916A1 Benzazepinone compound
05/22/2009CA2705642A1 Methods of treating or preventing inflammatory diseases of the intestinal tract
05/22/2009CA2704957A1 Compositions for the treatment of gastrointestinal inflammation
05/22/2009CA2704949A1 Gastrointestinal delivery systems
05/22/2009CA2704946A1 Compositions for the treatment of inflammation of the gastrointestinal tract
05/22/2009CA2704943A1 Compositions for the treatment of gastrointestinal inflammation
05/22/2009CA2703834A1 Silibinin component for the treatment of hepatitis
05/21/2009US20090131513 Anti-inflammatory modalities
05/21/2009US20090131484 Preventive or remedy for bowel disease
05/21/2009US20090131478 Growth Hormone Secretagogues
05/21/2009US20090131471 Compositions useful for treating gastroesophageal reflux disease
05/21/2009US20090131456 Caspase inhibitors and uses thereof
05/21/2009US20090131453 Benzylpiperazine derivatives as motilin receptor antagonists
05/21/2009US20090131418 Spiroazacyclic compounds as monoamine receptor modulators
05/21/2009US20090131404 Combinations
05/21/2009US20090131386 Compositions for the treatment of inflammation of the gastrointestinal tract
05/21/2009US20090131364 Bioactive fraction from zingier officinale and a process for the preparation thereof
05/21/2009US20090131350 Hybrid Hepatocyte Growth Factor Gene Having High Expression Efficiency of Two Heterotypes of Hepatocyte Growth Factor
05/21/2009US20090131343 Use of bridged macrolides or tylosin derivatives in treating inflammatory bowel diseases
05/21/2009US20090131341 Novel Dihydropseudoerythromycin Derivatives
05/21/2009US20090131330 Par-2 agonist
05/21/2009US20090131302 Transient receptor potential vanilloid 1 and uses thereof
05/21/2009US20090130762 Activation of HCV-specific T cells
05/21/2009US20090130225 Macrolides derivatives as antibacterial agents
05/21/2009US20090130203 Extracts of chenopodium ambrosioides l., the compositions comprising said extracts, the preparing process and application thereof
05/21/2009US20090130184 Compositions and methods for preventing or reducing postoperative ileus and gastric stasis
05/21/2009US20090130145 Vaccine
05/21/2009US20090130095 Composition comprising tumor necrosis factor (CD40) specific immunoglobulin for treatment and prevention of autoimmune diseases
05/21/2009US20090130077 Substituted benzoazole pde4 inhibitors for treating inflammatory, cardiovascular and cns disorders
05/21/2009US20090130063 Process for separating and determining the viral load in a pancreatin sample
05/21/2009US20090130062 Novel Application of Heparin-Binding Epidermal Growth Factor-Like Growth Factor for Medical Purposes
05/20/2009EP2060266A1 Y4 selective receptor agonists for therapeutic interventions
05/20/2009EP2060265A2 Cell-permeable peptide inhibitors of the JNK signal transduction pathway
05/20/2009EP2060255A2 Methods and compositions for prevention and treatment of inflammatory disease, autoimmune disease, and transplant rejection
05/20/2009EP2060183A2 Enteric formulations of proanthocyanidin polymer antidiarrheal compositions
05/20/2009EP2059247A1 Method and composition for promoting gastrointestinal bicarbonate secretion
05/20/2009EP2059241A1 Pharmaceutical combinations for lipid management and in the treatment of atherosclerosis and hepatic steatosis
05/20/2009EP2059234A1 Method for reducing or alleviating inflammation in the digestive tract
05/20/2009EP2059138A1 Polyphenol extraction process
05/20/2009EP2059136A1 Apples with high polyphenolic content
05/20/2009EP1807423B1 Quinolinone-carboxamide compounds